Trial · NCT02028884
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double-blind Period | STARTED | Placebo + Baseline Treatment, Then Satralizumab | 42 | |
| Double-blind Period | STARTED | Satralizumab + Baseline Treatment, Then Satralizumab | 42 | |
| Double-blind Period | STARTED | SA237 - Enrolled in Open-Label | 0 | |
| Double-blind Period | COMPLETED | Placebo + Baseline Treatment, Then Satralizumab | 32 | |
| Double-blind Period | COMPLETED | Satralizumab + Baseline Treatment, Then Satralizumab | 39 | |
| Double-blind Period | COMPLETED | SA237 - Enrolled in Open-Label | 0 | |
| Double-blind Period | NOT COMPLETED | Placebo + Baseline Treatment, Then Satralizumab | 10 | |
| Double-blind Period | NOT COMPLETED | Satralizumab + Baseline Treatment, Then Satralizumab | 3 | |
| Double-blind Period | NOT COMPLETED | SA237 - Enrolled in Open-Label | 0 | |
| Open-label Extension Period | STARTED | Placebo + Baseline Treatment, Then Satralizumab | 32 | |
| Open-label Extension Period | STARTED | Satralizumab + Baseline Treatment, Then Satralizumab | 39 | |
| Open-label Extension Period | STARTED | SA237 - Enrolled in Open-Label | 1 | |
| Open-label Extension Period | COMPLETED | Placebo + Baseline Treatment, Then Satralizumab | 23 | |
| Open-label Extension Period | COMPLETED | Satralizumab + Baseline Treatment, Then Satralizumab | 31 | |
| Open-label Extension Period | COMPLETED | SA237 - Enrolled in Open-Label | 1 | |
| Open-label Extension Period | NOT COMPLETED | Placebo + Baseline Treatment, Then Satralizumab | 9 | |
| Open-label Extension Period | NOT COMPLETED | Satralizumab + Baseline Treatment, Then Satralizumab | 8 | |
| Open-label Extension Period | NOT COMPLETED | SA237 - Enrolled in Open-Label | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02028884/flow